Vibe Bio

🚀 We're Hiring! Full-Stack Engineer (Remote)🚀 Are you or someone you know passionate about creating seamless user experiences and leveraging LLMs to accelerate biotech research? We're looking for a talented Full-Stack Engineer to join the Vibe Bio team! The ideal candidate will have experience with LLMs and their standard mechanics, such as tokenization, RAG, and context windows. This is a standard full-stack role, not a machine learning or data science one. Be an essential part of our product team, working closely with our Director of Product to develop and expand our core product. Ready to take the next step in your career? Be part of a forward-thinking team shaping the future! Visit https://lnkd.in/eAiNMjrn to learn more about this exciting new role. #ai #biotech #artificialintelligence #fullstack #react #developer #job #career

Last week, Biotech2050 hosted their first executive dinner event, in Cambridge, MA, where life sciences leaders gathered to discuss the importance of rare disease prevalence and genAI technology. Our CEO, Alok Tayi, PhD was joined by Samantha Baxter, Lukas Lange, and John Keilty in an intimate conversation sharing their insights on developments of AI in biotech. Thank you to all the panelists and guests for your valuable participation! We were delighted to sponsor the event alongside Probably Genetic. #Biotech #AI #Innovation #DrugDevelopment

🔬🚀 New Podcast Episode Alert! 🚀🔬 We are thrilled to reshare the latest episode of The DeSci Podcast, featuring our very own co-founder, Alok Tayi, PhD! We're dedicated to investing in biotech firms, with a special focus on rare and overlooked diseases. 🎙️ In this episode, Alok shares his deeply personal story of how medical conditions in his family inspired the creation of Vibe Bio. He discusses how we aim to identify diseases with unmet needs and leverage AI to find medicines with the highest chances of providing cures. Topics covered: -The complexities of drug development -Common misconceptions within the Biopharma industry -The utilization and methods used for training AI models -The issue of AI bias -The current limitations and challenges in leveraging AI to advance drug development 🔗 Tune in for an insightful conversation that bridges the gap between biotech and AI! 🎧 YouTube: https://lnkd.in/e_frdw43 X: https://lnkd.in/escSDzui Spotify: https://lnkd.in/eXp3v5f7 #biotech #lifesciences #drugdevelopment #AI #podcast #VibeBio #innovation #rarediseases #biopharma

JUST published our latest #VibeCast episode featuring an insightful chat with Toni Campbell, General Partner at Kinfolk Venture Capital. We delved into the burgeoning world of African entrepreneurship, the challenges faced by founders, and the incredible opportunities that lie ahead. Want valuable insights on investing in African biotech and fintech startups and the transformative impact they're poised to make? Don't miss out on this eye-opening discussion – tune in to the full episode on YouTube, Spotify, or Apple Podcasts now! YouTube: https://lnkd.in/edHj6Zv3 Spotify: https://lnkd.in/eY6Zy_QP "Life can only really be understood backwards, even though it's lived forward." - Toni Campbell #AfricanInnovation #VentureCapital #Startups #InvestingInAfrica

It takes a village... to develop and launch a new treatment. ICYMI: Sandra Shpilberg shares her story founding Adnexi, where her team is modernizing the process of finding key experts who can help drug developers develop/launch new drugs. It really is all about collaboration. Clinicians, regulatory experts, chemists, biologists, and many other influencers are critical to make a drug successful. Finding the right experts can be a huge challenge - that's where Sandra and her AI-driven software shines. Have you ever struggled to find the right KOLs for your drug program? To learn more, watch the full episode: https://lnkd.in/e3Xyk5Be

Not too many Mother-Son duos building software companies, but I'm delighted to be a part of one. Biopharma companies rely on key external experts to accelerate development and launch. At Adnexi we've been working for the last 4 years to craft the best solution. I'm grateful to have the opportunity to build this with the next generation and thanks to Vibe Bio for this episode. Coby Shpilberg Andrew Snyder Stephanie Pinc Austin Harrison #KOL #AI #startup #drugdevelopment #biopharma #keyopinionleaders #DOL #doctors #researchers

🎙️ EPISODE 50 🎙️ Dive into the newest episode of #Vibecast, where Sandra Shpilberg, co-founder of Adnexi, shares how she and her son are transforming the pharma KOL identification process. Our show host, Ray Dogum, and Sandra discuss some of the innovative strategies using AI to find key opinion leaders and digital influencers to accelerate drug development research and ultimately product launch. Every drug dev program needs a variety of experts to move the drug from preclinical all the way through clinical trials and FDA approval. Finding the right doctors and scientific experts can be a challenge for many drug dev teams. Hear how Adnexi is tackling this problem with artificial intelligence and social media. Don't miss this enlightening discussion - tune in on Spotify and YouTube! YouTube: https://lnkd.in/eHqhW3tX Spotify: https://lnkd.in/ezdugU7J #KOL #influencer #ai #doctors #researchers #socialmedia #keyopinionleaders #experts #pharma #drugdevelopment

🎙 Episode 49 of #VibeCast is here! Roy de Souza, founder & CEO of BreakBio Corp, joins VibeCast host, Ray Dogum in a discussion on BreakBio's origins, the origins of cancer itself, and how Roy's team is developing novel cancer vaccines for colorectal cancers using artificial intelligence. Full episodes can be found 👇 YouTube: https://lnkd.in/ebw4bnZd Spotify: https://lnkd.in/ewCwqEJw #vaccine #cancer #ai #missiondriven

What is the biggest issue with the available #biotech financing models? How would you go about fixing it?🧐

Here are some of the best #biotech financing options we've seen: Grant Funding Venture Capital (VC) Angel Investors Strategic Partnerships PIPEs What are we missing?🤔